Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives
- PMID: 24486525
- DOI: 10.1016/j.bcp.2014.01.024
Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives
Abstract
Aminoindanes, piperazines, and pipradrol derivatives are novel psychoactive substances found in "Ecstasy" tablets as replacements for 3,4-methylenedioxymethamphetamine (MDMA) or substances sold as "ivory wave." The pharmacology of these MDMA- and methylphenidate-like substances is poorly known. We characterized the pharmacology of the aminoindanes 5,6-methylenedioxy-2-aminoindane (MDAI), 5-iodoaminoindane (5-IAI), and 2-aminoindane (2-AI), the piperazines meta-chlorophenylpiperazine (m-CPP), trifluoromethylphenylpiperazine (TFMPP), and 1-benzylpiperazine (BZP), and the pipradrol derivatives desoxypipradrol (2-diphenylmethylpiperidine [2-DPMP]), diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM]), and methylphenidate. We investigated norepinephrine (NE), dopamine (DA), and serotonin (5-hydroxytryptamine [5-HT]) uptake inhibition using human embryonic kidney 293 (HEK 293) cells that express the respective human monoamine transporters (NET, DAT, and SERT). We also evaluated the drug-induced efflux of NE, DA, and 5-HT from monoamine-preloaded cells and the binding affinity to monoamine transporters and receptors, including trace amine-associated receptor 1 (TAAR1). 5-IAI and MDAI preferentially inhibited the SERT and NET and released 5-HT. 2-AI interacted with the NET. BZP blocked the NET and released DA. m-CPP and TFMPP interacted with the SERT and serotonergic receptors. The pipradrol derivatives were potent and selective catecholamine transporter blockers without substrate releasing properties. BZP, D2PM, and 2-DPMP lacked serotonergic activity and TAAR1 binding, in contrast to the aminoindanes and phenylpiperazines. In summary, all of the substances were monoamine transporter inhibitors, but marked differences were found in their DAT vs. SERT inhibition profiles, release properties, and receptor interactions. The pharmacological profiles of D2PM and 2-DPMP likely predict a high abuse liability.
Keywords: Monoamine; Novel psychoactive substance; Receptor; Transporter.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.Eur Neuropsychopharmacol. 2015 Mar;25(3):365-76. doi: 10.1016/j.euroneuro.2014.12.012. Epub 2015 Jan 5. Eur Neuropsychopharmacol. 2015. PMID: 25624004
-
Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP).Clin Toxicol (Phila). 2012 Sep;50(8):727-32. doi: 10.3109/15563650.2012.716158. Epub 2012 Aug 10. Clin Toxicol (Phila). 2012. PMID: 22882169 Review.
-
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').Neuropsychopharmacology. 2005 Mar;30(3):550-60. doi: 10.1038/sj.npp.1300585. Neuropsychopharmacology. 2005. PMID: 15496938
-
2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors.Psychopharmacology (Berl). 2019 Mar;236(3):989-999. doi: 10.1007/s00213-019-05207-1. Epub 2019 Mar 23. Psychopharmacology (Berl). 2019. PMID: 30904940 Free PMC article.
-
Designer psychostimulants: pharmacology and differences.Neuropharmacology. 2014 Dec;87:59-65. doi: 10.1016/j.neuropharm.2014.01.015. Epub 2014 Jan 20. Neuropharmacology. 2014. PMID: 24456744 Review.
Cited by
-
Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications.Life (Basel). 2021 May 14;11(5):440. doi: 10.3390/life11050440. Life (Basel). 2021. PMID: 34068903 Free PMC article. Review.
-
The Role of Dopamine in the Stimulant Characteristics of Novel Psychoactive Substances (NPS)-Neurobiological and Computational Assessment Using the Case of Desoxypipradrol (2-DPMP).Front Pharmacol. 2020 Jun 5;11:806. doi: 10.3389/fphar.2020.00806. eCollection 2020. Front Pharmacol. 2020. PMID: 32670057 Free PMC article.
-
Positive allosteric mGluR2 modulation with BINA alleviates dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset.Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8917-8924. doi: 10.1007/s00210-024-03215-3. Epub 2024 Jun 11. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38861009
-
Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α2-adrenoceptor and trace amine-associated receptor 1 ligand.Pharmacol Rep. 2023 Oct;75(5):1211-1229. doi: 10.1007/s43440-023-00518-9. Epub 2023 Aug 25. Pharmacol Rep. 2023. PMID: 37624466 Free PMC article.
-
Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs.J Cheminform. 2022 Jun 7;14(1):35. doi: 10.1186/s13321-022-00607-6. J Cheminform. 2022. PMID: 35672835 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous